/주식/RXRX
RXRX

RXRX

USD

Recursion Pharmaceuticals Inc. Class A Common Stock

$5.000-0.200 (-3.846%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$5.200

고가

$5.320

저가

$4.970

거래량

57.15M

기업 기본 정보

시가총액

2.2B

산업

생명공학

국가

United States

거래 통계

평균 거래량

39.05M

거래소

NMS

통화

USD

52주 범위

저가 $3.79현재가 $5.000고가 $12.36

관련 뉴스

GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following

더 보기
Recursion to Participate in Upcoming Investor Conferences
GlobeNewswire

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and

더 보기
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Reuters

Buybacks take backseat as AI drives record US capex spending

Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.

더 보기
Buybacks take backseat as AI drives record US capex spending